After showing that the m1A writer enzyme TRMT10C was consistently upregulated in AD models and human AD cortex samples, we scrutinized a plausible implication, namely if m1A levels in ND5 mRNA would be elevated in AD pathology as pointed out in our hypothesis (ii). The gene discussed is TRMT10C; the disease is Alzheimer disease.